AM
IONS icon

AGF Management’s Ionis Pharmaceuticals IONS Stock Holding History

AGF Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-87,867
Closed -$3.61M – 750
2023
Q2 		$3.61M Sell
87,867
-6,758
-7% -$260K 0.03% 345
2023
Q1 		$3.38M Buy
+94,625
New +$3.55M 0.02% 372

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AGF Management's IONS Position: Q3 2023 in Review

AGF Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2023, closing a stake of 87,867 shares — an estimated $3.61M sold.

AGF Management first reported a position in IONS in Q1 2023 and held it in 2 quarters. The position peaked at $3.61M in Q2 2023. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.

  • AGF Management reported no remaining Ionis Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • AGF Management sold 87,867 Ionis Pharmaceuticals shares in Q3 2023, an estimated $3.61M.
  • AGF Management first reported a position in Ionis Pharmaceuticals in Q1 2023 and held it in 2 quarters.
  • AGF Management's Ionis Pharmaceuticals position peaked at $3.61M in Q2 2023.
  • 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.

Based on AGF Management's 13F filing for Q3 2023, filed 13 Nov 2023.